Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status

[1]  M. Matsuoka,et al.  HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors , 2015, Journal of NeuroVirology.

[2]  R. Césaire,et al.  Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases , 2015, Viruses.

[3]  M. Matsuoka,et al.  HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival. , 2015, Cancer research.

[4]  M. Matsuoka,et al.  Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor. , 2015, Blood.

[5]  R. Mahieux.  A vaccine against HTLV-1 HBZ makes sense. , 2015, Blood.

[6]  C. Bidoia,et al.  Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL , 2015, Retrovirology.

[7]  M. Matsuoka,et al.  Reevaluation of confirmatory tests for human T‐cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors , 2015, Transfusion.

[8]  A. Lazzarin,et al.  The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study , 2014, Retrovirology.

[9]  S. Jacobson,et al.  Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals , 2013, Retrovirology.

[10]  S. Jacobson,et al.  Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica. , 2012, Blood.

[11]  A. Corradin,et al.  Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. , 2011, Blood.

[12]  Aidan MacNamara,et al.  In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. , 2011, The Journal of infectious diseases.

[13]  K. Ohshima,et al.  HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo , 2011, PLoS pathogens.

[14]  M. Matsuoka.  HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis. , 2010, Molecular aspects of medicine.

[15]  Aidan MacNamara,et al.  HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection , 2010, PLoS pathogens.

[16]  K. Yamaguchi,et al.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.

[17]  M. Matsuoka,et al.  APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo , 2010, Journal of Virology.

[18]  M. Matsuoka,et al.  HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. , 2009, The Journal of general virology.

[19]  Kousuke Saito,et al.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) , 2009, Retrovirology.

[20]  Joshua Arnold,et al.  Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. , 2008, Blood.

[21]  F. Kashanchi,et al.  Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) , 2008, Retrovirology.

[22]  Yasuaki Yamada,et al.  Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells , 2008, Retrovirology.

[23]  F. Raymond,et al.  The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies , 2007, Retrovirology.

[24]  T. Koji,et al.  A Novel Alternative Splicing Isoform of Human T-Cell Leukemia Virus Type 1 bZIP Factor (HBZ-SI) Targets Distinct Subnuclear Localization , 2006, Journal of Virology.

[25]  Jun-ichirou Yasunaga,et al.  HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Landry,et al.  HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated , 2006, Retrovirology.

[27]  M. Ciccozzi,et al.  The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters. , 2005, The Journal of infectious diseases.

[28]  B. Gay,et al.  Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs , 2005, Journal of Cell Science.

[29]  T. Fujiyoshi,et al.  Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy , 1996, Journal of Neurology.

[30]  M. Biard-Piechaczyk,et al.  The Complementary Strand of the Human T-Cell Leukemia Virus Type 1 RNA Genome Encodes a bZIP Transcription Factor That Down-Regulates Viral Transcription , 2002, Journal of Virology.

[31]  S. Izumo,et al.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.

[32]  S. Izumo,et al.  Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cells , 1987, Annals of neurology.

[33]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[34]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[35]  K. Yamaguchi,et al.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Ferguson,et al.  Letter: Lymphoid cells in jejunal mucosa. , 1975, Lancet.

[37]  H. Towler,et al.  Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .